Sunshine Biopharma (SBFMW) Tax Provisions (2022 - 2025)
Sunshine Biopharma (SBFMW) reported Tax Provisions of $408374.0 for Q4 2025, up 417.22% on a YoY basis from $78956.2 in Q4 2024, and up 397.13% quarter-over-quarter from -$137438.0 in Q3 2025.
Sunshine Biopharma (SBFMW) Tax Provisions (2022 - 2025) Analysis & Trends
Sunshine Biopharma has reported Tax Provisions for 4 years, with the latest figure at $408374.0 in Q4 2025.
- For the quarter ending Q4 2025, Tax Provisions rose 417.22% year-over-year to $408374.0; the trailing twelve-month figure through Mar 2026 stood at $61770.0 (up 120.77% YoY), and the FY2025 full-year result was $21609.0, up 109.2% from the prior year.
- Tax Provisions for Q4 2025 stood at $408374.0, up from -$137438.0 in the prior quarter.
- The five-year high for Tax Provisions was $408374.0 in Q4 2025, with the low at -$343691.0 in Q2 2024.
- Historically, Tax Provisions has averaged $31940.1 across 4 years, with a median of $40952.0 in 2023.
- The largest YoY upside for Tax Provisions was 425.53% in 2024 against a maximum downside of 492.0% in 2024.
- Sunshine Biopharma's Tax Provisions stood at $233304.0 in 2022, then slipped by 5.59% to $220267.0 in 2023, then slumped by 158.45% to -$128737.0 in 2024, then jumped by 417.22% to $408374.0 in 2025.
- The last three Tax Provisions figures came in at $408374.0 (Q4 2025), -$137438.0 (Q3 2025), and -$209166.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 67.00 Mn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 157.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 43.40 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 48.90 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | 14.17 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 30.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | 4.60 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 37.99 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 3.90 Mn |
| 10 | Sunshine Biopharma | - | - | 2.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 408,374.00 |
| Sep 30, 2025 | -137,438.00 |
| Jun 30, 2025 | -209,166.00 |
| Mar 31, 2025 | -40,161.00 |
| Dec 31, 2024 | -128,737.00 |
| Sep 30, 2024 | 215,217.00 |
| Jun 30, 2024 | -343,691.00 |
| Mar 31, 2024 | 22,353.00 |
| Dec 31, 2023 | 220,267.00 |
| Sep 30, 2023 | 40,952.00 |
| Jun 30, 2023 | 87,677.00 |
| Mar 31, 2023 | 46,270.00 |
| Dec 31, 2022 | 233,304.00 |